NEW YORK (GenomeWeb News) – Thermo Fisher Scientific said after the close of the market Tuesday that it has extended until midnight, New York City time, on April 7, its tender offer to acquire all of the outstanding shares of Dionex.
Thermo Fisher inked the deal in December to acquire Dionex for $118.50 per share in cash for a total transaction value of $2.1 billion. The tender offer represented a 21 percent premium to Dionex's closing share price of $98.17 on Dec. 10, the last trading day prior to the announcement.
As of 5:00 pm, New York City time, on Feb. 15, approximately 9.1 million shares of Dionex's common stock, representing around 52 percent of all outstanding shares, had been tendered and not withdrawn from the offer.
The deal already has cleared US antitrust review, and Thermo Fisher expects to close the deal early in the second quarter, it said yesterday.